Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control - PubMed (original) (raw)
. 2017 Nov;40(11):1425-1432.
doi: 10.2337/dc16-1974. Epub 2017 Aug 11.
Affiliations
- PMID: 28801473
- DOI: 10.2337/dc16-1974
Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control
Steven V Edelman et al. Diabetes Care. 2017 Nov.
Abstract
Despite U.S. Food and Drug Administration (FDA) approval of over 40 new treatment options for type 2 diabetes since 2005, the latest data from the National Health and Nutrition Examination Survey show that the proportion of patients achieving glycated hemoglobin (HbA1c) <7.0% (<53 mmol/mol) remains around 50%, with a negligible decline between the periods 2003-2006 and 2011-2014. The Healthcare Effectiveness Data and Information Set reports even more alarming rates, with only about 40% and 30% of patients achieving HbA1c <7.0% (<53 mmol/mol) in the commercially insured (HMO) and Medicaid populations, respectively, again with virtually no change over the past decade. A recent retrospective cohort study using a large U.S. claims database explored why clinical outcomes are not keeping pace with the availability of new treatment options. The study found that HbA1c reductions fell far short of those reported in randomized clinical trials (RCTs), with poor medication adherence emerging as the key driver behind the disconnect. In this Perspective, we examine the implications of these findings in conjunction with other data to highlight the discrepancy between RCT findings and the real world, all pointing toward the underrealized promise of FDA-approved therapies and the critical importance of medication adherence. While poor medication adherence is not a new issue, it has yet to be effectively addressed in clinical practice-often, we suspect, because it goes unrecognized. To support the busy health care professional, innovative approaches are sorely needed.
© 2017 by the American Diabetes Association.
Comment in
- Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432.
Giugliano D, Maiorino MI, Bellastella G, Esposito K. Giugliano D, et al. Diabetes Care. 2018 Feb;41(2):e17. doi: 10.2337/dc17-1826. Diabetes Care. 2018. PMID: 29358471 No abstract available. - Response to Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432.
Edelman SV, Polonsky WH. Edelman SV, et al. Diabetes Care. 2018 Feb;41(2):e18. doi: 10.2337/dci17-0050. Diabetes Care. 2018. PMID: 29358472 No abstract available.
Similar articles
- Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes.
Carls GS, Tuttle E, Tan RD, Huynh J, Yee J, Edelman SV, Polonsky WH. Carls GS, et al. Diabetes Care. 2017 Nov;40(11):1469-1478. doi: 10.2337/dc16-2725. Epub 2017 Aug 11. Diabetes Care. 2017. PMID: 28801475 - Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.
Chow W, Miyasato G, Kokkotos FK, Bailey RA, Buysman EK, Henk HJ. Chow W, et al. Clin Ther. 2016 Sep;38(9):2071-82. doi: 10.1016/j.clinthera.2016.07.168. Epub 2016 Sep 3. Clin Ther. 2016. PMID: 27596020 - Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
Farmer AJ, Rodgers LR, Lonergan M, Shields B, Weedon MN, Donnelly L, Holman RR, Pearson ER, Hattersley AT. Farmer AJ, et al. Diabetes Care. 2016 Feb;39(2):258-263. doi: 10.2337/dc15-1194. Epub 2015 Dec 17. Diabetes Care. 2016. PMID: 26681714 Free PMC article. - The economic rationale for adherence in the treatment of type 2 diabetes mellitus.
Wild H. Wild H. Am J Manag Care. 2012 Apr;18(3 Suppl):S43-8. Am J Manag Care. 2012. PMID: 22558941 Review. - Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Maiorino MI, Chiodini P, Bellastella G, Capuano A, Esposito K, Giugliano D. Maiorino MI, et al. Diabetes Care. 2017 Apr;40(4):614-624. doi: 10.2337/dc16-1957. Diabetes Care. 2017. PMID: 28325801 Review.
Cited by
- The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial.
Thomsen CHN, Nørlev JTD, Hangaard S, Jensen MH, Hejlesen O, Cohen SR, Kofoed-Enevoldsen A, Kristensen SNS, Aradóttir TB, Kaas A, Vestergaard P, Kronborg T. Thomsen CHN, et al. Trials. 2024 Nov 8;25(1):744. doi: 10.1186/s13063-024-08588-7. Trials. 2024. PMID: 39511648 Free PMC article. - Treatment of type 2 diabetes and stress using neuro-emotional technique: case report.
Bablis P, Day RR, Pollard H. Bablis P, et al. Front Endocrinol (Lausanne). 2024 Jul 10;15:1382757. doi: 10.3389/fendo.2024.1382757. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39050563 Free PMC article. - Beneficial Effect of Remote Glucose Monitoring and Computerized Insulin Dose Adjustment Algorithms Independent of Insulin Dose Increases in Sizeable Minorities of Patients.
Davidson MB, Davidson SJ, Duran P. Davidson MB, et al. Clin Diabetes. 2024 Summer;42(3):364-370. doi: 10.2337/cd23-0066. Epub 2023 Dec 27. Clin Diabetes. 2024. PMID: 39015160 - Liposome Encapsulation Enhances the Antidiabetic Efficacy of Silibinin.
Dinić S, Arambašić Jovanović J, Uskoković A, Jovanović A, Grdović N, Rajić J, Đorđević M, Sarić A, Bugarski B, Vidaković M, Mihailović M. Dinić S, et al. Pharmaceutics. 2024 Jun 13;16(6):801. doi: 10.3390/pharmaceutics16060801. Pharmaceutics. 2024. PMID: 38931922 Free PMC article. - Association between single and mixed exposure to polycyclic aromatic hydrocarbons and biological aging.
Fu Z, Zhang X, Zhong C, Gao Z, Yan Q. Fu Z, et al. Front Public Health. 2024 Jun 5;12:1379252. doi: 10.3389/fpubh.2024.1379252. eCollection 2024. Front Public Health. 2024. PMID: 38903587 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous